Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.
Press releases published on August 21, 2025
Vaidio Launches 9.1 Release, Accelerates Enterprise Vision AI with Next-Generation Features
GlobeNewswire
·
August 21, 2025
SAN JOSE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Vaidio, a leader in Vision AI, today launched Vaidio 9.1. This new release gives enterprises faster, easier access to AI-driven insights from visual data. With 9.1, organizations can turn video into real- …
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
GlobeNewswire
·
August 21, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the dosing of the first …
KAPPA AgTech Ventilated Lighting Named “Lighting System of the Year” By AgTech Breakthrough
GlobeNewswire
·
August 21, 2025
LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural and food technology markets today, today announced that …
Immuneering Announces $25 Million Private Placement
GlobeNewswire
·
August 21, 2025
CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it has entered into a definitive securities purchase agreement for …
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 21, 2025
TEL AVIV, Israel, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that …
Rezolve Ai to Participate in Citi’s 2025 Global TMT Conference
GlobeNewswire
·
August 21, 2025
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, announced that its Founder and Chief Executive Officer, Daniel M. Wagner, will participate in a fireside …
VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
GlobeNewswire
·
August 21, 2025
MUNICH, Aug. 21, 2025 (GLOBE NEWSWIRE) -- VeonGen Therapeutics, a clinical-stage genetic medicine company developing next-generation gene therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced …
Agricultural and Food Technology Innovators Honored in 5th Annual AgTech Breakthrough Awards Program
GlobeNewswire
·
August 21, 2025
LOS ANGELES, Aug. 21, 2025 (GLOBE NEWSWIRE) -- AgTech Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global agricultural and food technology markets, today announced the featured …
Advent Technologies and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing
GlobeNewswire
·
August 21, 2025
LIVERMORE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation driven leader in the fuel cell and hydrogen technology space, has entered into an agreement with a U.S. based global leader in …
FED Fitness Launches its Limited-Time YOSUDA Exercise Bike 002 Sale
GlobeNewswire
·
August 21, 2025
Hong Kong, China, Aug. 21, 2025 (GLOBE NEWSWIRE) -- FED Fitness, the No.1 best-selling brand in the home fitness gear category with over 10 million family users worldwide, has announced a limited-time promotion on its best-selling YOSUDA Exercise Bike 002. …
Pyxis Oncology to Participate in September Investor and Industry Conferences
GlobeNewswire
·
August 21, 2025
BOSTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing antibody-drug conjugate (ADC) therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief …
InflaRx Announces Participation in September Investor Conferences
GlobeNewswire
·
August 21, 2025
JENA, Germany, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced it will participate in two investor conferences in …
Kraig Biocraft Laboratories Announces Commencement of Full Operations at Second Production Rearing Center in Southeast Asia
GlobeNewswire
·
August 21, 2025
ANN ARBOR, Mich., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces that its second production rearing center in Southeast Asia is now fully …
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire
·
August 21, 2025
RESEARCH TRIANGLE PARK, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the Cantor Global Healthcare Conference in New York on Thursday, September 4, 2025, at 9:45 a …
Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book
GlobeNewswire
·
August 21, 2025
SOLANA BEACH, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, today …
Skye Bioscience to Participate in Upcoming Investment and Medical Conferences
GlobeNewswire
·
August 21, 2025
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, today announced that it will …
Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir
GlobeNewswire
·
August 21, 2025
BRECKENRIDGE, Colo., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to announce its latest innovation, Mountain Shot, a crafted …
Lantronix to Participate in The Gateway Conference in September
GlobeNewswire
·
August 21, 2025
IRVINE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that CEO Saleel Awsare and CFO Brent Stringham will participate in the …
Tenable Names Matthew Brown as Chief Financial Officer
GlobeNewswire
·
August 21, 2025
COLUMBIA, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Tenable® (NASDAQ: TENB), the exposure management company, today announced the appointment of Matthew Brown as Chief Financial Officer, effective immediately. Brown succeeds Steve Vintz, who recently was …
I-Mab to Participate in September Investor Conferences
GlobeNewswire
·
August 21, 2025
ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s …